Skip to main content

Table 5 Frequency of nausea and vomiting AEs during 1 st cycle of chemotherapy

From: Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial

Frequency of nausea and vomiting AE (all grade) during 1st cycle of chemotherapy

 

Placebo n = 217

Cocculine ® n = 214

All n = 431

p

Missing data

39

20

59

 

Number of patients evaluable

178

194

372

 

Number of patient with at least 1 AE nausea (%)

91 (51.1)

92 (47.4)

83 (49.2)

0.48

Missing data

39

20

59

 

Number of patients evaluable

178

194

372

 

Number of patient with at least 1 AE vomiting, n (%)

35 (19.7)

41 (21.1)

76 (20.4)

0.72

Frequency of severe nausea and vomiting AE (Grade ≥ 2) during 1 st cycle of chemotherapy

 

Placebo n = 217

Cocculine n = 214

All n = 431

p

Missing data

47

29

76

 

Number of patients evaluable, n

170

185

355

 

Number of patient with at least 1 severe nausea AE (i.e. Grade ≥2), n (%)

30 (17.6)

29 (15.7)

59 (16.6)

0.62

Missing data

41

22

63

 

Number of patients evaluable

176

192

368

 

Number of patient with at least 1 severe vomiting AE (i.e. Grade ≥ 2), n (%)

19 (10.8)

23 (12.0)

42 (11.4)

0.72

  1. †Person’s chi-square test.